Mr. Chan Yiu Lun reports
ACQUISITION OF SHARES BY SUBSTANTIAL SHAREHOLDER OF BURCON NUTRASCIENCE CORPORATION
On Jan. 14, 2019, Chan Yiu Lun (Alan), a director of Burcon NutraScience Corp., through his indirect wholly owned company, Large Scale Investments Ltd., a company incorporated in the British Virgin Islands, entered into a private agreement for the sale and purchase to acquire, from Dr. Allan Yap, 1,566,719 common shares in the capital of Burcon at a total consideration of $1,843,000 (Hong Kong) (approximately $311,792 based on the exchange rate of $1 equals $5.911 (Hong Kong). Transfer of the sale shares to Large Scale was to take place on Jan. 14, 2019, after signing of the agreement.
Before the acquisition:
- Mr. Chan, through his indirect wholly owned companies, Large Scale and Great Intelligence Ltd., was deemed to beneficially own: (i) 9,866,568 common shares (the preacquisition shares") in the capital of Burcon, amongst which 7,225,510 common shares are held by Large Scale and 2,641,058 common shares are held by Great Intelligence; and (ii) the convertible unsecured 8 per cent promissory note in the principal amount of $2-million held by Large Scale, which is convertible into 507,614 Burcon common shares at a price of $3.94 per share (subject to adjustments) during the period commencing on or after July 1, 2016, and up to and including the maturity date, which is the earlier of: (a) three years from the issue of the note; and (b) the occurrence of an event of default.
- Mr. Chan does not hold any Burcon common shares but holds 210,844 options issued by Burcon, which are exercisable by Mr. Chan to purchase Burcon common shares at various exercise prices ranging from 69 cents to $8.65 per share.
As a result of the acquisition, the number of Burcon shares held by Large Scale increased from 7,225,510 to 8,792,229. Since Mr. Chan was deemed to control Large Scale and Great Intelligence, he was also deemed to beneficially own the sale shares, the preacquisition shares and the note. The total number of Burcon shares held by Large Scale and Great Intelligence, which Mr. Chan was deemed to beneficially own, increased from 9,866,568 (22.45 per cent) to 11,433,287 (26.02 per cent) (the postacquisition shares). The aforementioned percentage is calculated based on 43,941,536 issued and outstanding common shares of Burcon as of Jan. 14, 2019.
If Mr. Chan and Large Scale were to exercise all of Mr. Chan's options and the note, Mr. Chan may then be deemed to beneficially own 12,151,745 Burcon common shares (including the 11,433,287 postacquisition shares), representing approximately 27.21 per cent of the issued and outstanding Burcon shares as at Jan. 14, 2019, assuming that all Mr. Chan's options and the note are exercised/converted but that no other convertible securities of Burcon are exercised.
It is intended that the sale shares acquired by Large Scale will be held for investment purposes. Mr. Chan may, depending on market and other conditions, increase or decrease his beneficial ownership of Burcon's securities, whether in the open market, by privately negotiated agreements or otherwise, subject to a number of factors, including general market conditions and other available investment and business opportunities.
For further information, or to obtain a copy of the subject early warning report filed by Mr. Chan in accordance with applicable Canadian securities laws, please contact the director of Large Scale at 852-2831-8118.
© 2019 Canjex Publishing Ltd. All rights reserved.